NASDAQ · Biotechnology

ADTX (ADTX) Stock

$0.01 -77.22% NASDAQ: ADTX Healthcare

Valuation

MetricValue
Price$0.01
Market Cap$318
P/E Ratio-0.01
P/B Ratio0.08
P/S Ratio0.09
EPS (TTM)$-1153.83
52-Week High$2495.04
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-150.77%
ROA-180.91%
ROCE-495.00%
Gross Margin8.39%
Operating Margin-6125.42%
Net Margin-13056.09%
Debt/Equity535.95
Current Ratio0.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$1.0M$0$0
Operating Profit$-42.0M$-25.0M$-26.0M$-28.0M$-20.0M
Net Profit$-46.0M$-28.0M$-32.0M$-34.0M$-42.0M
EPS$-2.43$-14.89$-249623.74$-346053.00$-1153.83
Op Margin-39925.2%-2728.9%-4039.6%-20796.4%-612542.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.0M$11.0M$45.0M$32.0M$17.0M
Total Liabilities$6.0M$6.0M$29.0M$24.0M$13.0M
Cash$8.0M$3.0M$0$1.0M$3.2B
Borrowings$5.0M$3.0M$18.0M$7.0M$3.0B

Latest News

ADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish? Stocktwits · Jun 25, 2026 BC-Most Active Stocks Associated Press · Jun 17, 2026 Top Premarket Decliners MT Newswires · Jun 17, 2026 Top Premarket Gainers MT Newswires · Jun 12, 2026 ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff? Stocktwits · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-22.0M$-19.0M$-17.0M$-25.7B
Investing Cash Flow$-17.0M$-1.0M$0$-5.0M$-2.5B
Financing Cash Flow$3.0M$1.0M$1.0M$3.0M$30.5B
Net Cash Flow$-3.0M$-5.0M$-3.0M$1.0M$2.4B
Free Cash Flow$-23.0M$-23.0M$-19.0M$-17.0M$-25.7B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-4416169.42%
Quick Ratio-0.16
Interest Coverage-10.00
Return 1Y-100.00%
Return 3Y-100.00%
Return 5Y-100.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIMDAinos, Inc. $1.21 +0.00% -0.54 $8.91M 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
APLMApollomics Inc. $21.50 -1.29% -2.84 $47.22M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BLRXBioLineRx Ltd. $2.85 -2.45% -1.36 $12.39M 0.00%

About ADTX

ADTX is led by CEO Amro A. Albanna, employs 26 people, headquartered in US, publicly traded since 2020.

ADTX stock trades at $0.01 with a market capitalization of $318. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.08, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $0.01 and $2495.04, and currently trades 100.0% below its 52-week high.

On profitability, ADTX generates a return on equity (ROE) of -150.77%, return on capital employed of -495.00%, an operating margin of -6125.42%, a net profit margin of -13056.09%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides